Phathom Pharmaceuticals Inc (PHAT)
4.99 +0.15 (+3.10%) 09:32 ET [NASDAQ]
4.99 x 48 5.07 x 100
Realtime by (Cboe BZX)
4.99 x 48 5.07 x 100
Realtime 5.10 +0.26 (+5.34%) 09:10 ET
for Tue, Mar 18th, 2025
Results
download Want to compare other data? Select FieldsSymbol | PHAT | AZN | AMGN | GILD | VRTX |
Company | Phathom Pharmaceuticals Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 4.94 | 77.64 | 316.70 | 111.85 | 505.20 |
High | 4.94 | 77.64 | 316.70 | 111.85 | 517.20 |
Low | 4.94 | 77.64 | 316.70 | 111.85 | 504.00 |
Last | 4.99 | 77.37 | 316.33 | 111.75 | 510.21 |
Change | +0.15 | +0.27 | -0.84 | -0.51 | -3.55 |
% Change | +3.10% | +0.35% | -0.26% | -0.45% | -0.69% |
Volume | 3,580 | 75,539 | 2,053 | 3,151 | 1,108,900 |
20-Day Average Volume | 1,143,784 | 6,020,977 | 2,991,393 | 9,148,987 | 1,378,745 |
Previous Close | 4.84 | 77.37 | 317.17 | 112.26 | 504.77 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 5.27 | 76.06 | 312.10 | 113.06 | 486.71 |
20-Day Raw Stochastic | 29.90% | 85.15% | 56.49% | 45.05% | 91.25% |
20-Day Relative Strength | 42.79% | 62.96% | 60.25% | 60.19% | 66.68% |
Weighted Alpha | -43.57 | +15.51 | +13.85 | +63.63 | +24.80 |
Today's Opinion | 100% Sell | 56% Buy | 56% Buy | 88% Buy | 40% Buy |
Previous Opinion | 100% Sell | 56% Buy | 56% Buy | 88% Buy | 40% Buy |
Last Month's Opinion | 100% Sell | 8% Sell | 40% Sell | 100% Buy | 8% Sell |
Performance | |||||
5-Days | |||||
%Chg | +3.13% since 03/11/25 | +4.58% since 03/11/25 | -0.69% since 03/11/25 | -2.25% since 03/11/25 | +2.75% since 03/10/25 |
Low | 4.07 on 03/14/25 | 74.68 on 03/12/25 | 308.64 on 03/12/25 | 109.46 on 03/17/25 | 480.28 on 03/11/25 |
High | 5.25 on 03/12/25 | 77.76 on 03/17/25 | 318.66 on 03/17/25 | 115.46 on 03/13/25 | 519.68 on 03/14/25 |
1-Month | |||||
%Chg | -13.64% since 02/18/25 | +3.80% since 02/18/25 | +8.16% since 02/18/25 | +6.27% since 02/18/25 | +11.93% since 02/14/25 |
Low | 4.07 on 03/14/25 | 73.54 on 02/21/25 | 291.80 on 02/19/25 | 105.20 on 02/19/25 | 451.99 on 02/18/25 |
High | 6.98 on 03/06/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
3-Month | |||||
%Chg | -38.17% since 12/18/24 | +20.11% since 12/18/24 | +22.38% since 12/18/24 | +23.33% since 12/18/24 | +9.49% since 12/17/24 |
Low | 4.07 on 03/14/25 | 63.75 on 12/20/24 | 253.30 on 12/19/24 | 88.57 on 01/10/25 | 377.85 on 12/19/24 |
High | 8.34 on 01/02/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
6-Month | |||||
%Chg | -74.31% since 09/18/24 | -1.20% since 09/18/24 | -4.87% since 09/18/24 | +33.33% since 09/18/24 | +6.75% since 09/17/24 |
Low | 4.07 on 03/14/25 | 62.75 on 11/18/24 | 253.30 on 12/19/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
High | 19.71 on 09/19/24 | 79.76 on 10/02/24 | 339.17 on 09/23/24 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
Key Statistics | |||||
Market Capitalization, $K | 337,043 | 239,936,928 | 170,385,312 | 139,802,544 | 131,928,440 |
Shares Outstanding, K | 69,637 | 3,101,162 | 537,205 | 1,245,346 | 256,790 |
Annual Sales | 55,250,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
Annual Net Income | -334,330,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
Last Quarter Sales | 29,660,000 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
Last Quarter Net Income | -74,450,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
60-Month Beta | 0.64 | 0.41 | 0.53 | 0.21 | 0.41 |
Per-Share Information | |||||
Most Recent Earnings | -0.79 on 03/06/25 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.90 on 02/11/25 | 3.98 on 02/10/25 |
Latest Earnings Date | 05/08/25 | 04/24/25 | 05/01/25 | 04/24/25 | 05/05/25 |
Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 03/14/25 | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 18.88 | 15.83 | 24.17 | 0.00 |